Stéphane Bancel said his company’s planned price hike to $130 a dose covers the challenges of commercial sales. Sen. Sanders called it part of industry’s “unprecedented level of corporate greed.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,